APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Central Nervous System (CNS) Drug

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Central Nervous System (CNS) Drug Industry Growth and Trends Forecast to 2032

Report ID 173976380131 December 2025104 pages

Choose your research edition.

Industry ResearchCentral Nervous System (CNS) Drug Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Central Nervous System (CNS) Drug Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Central Nervous System (CNS) Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Central Nervous System (CNS) Drug Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Central Nervous System (CNS) Drug Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

According to APO Research, the global Central Nervous System (CNS) Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Central Nervous System (CNS) Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Central Nervous System (CNS) Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Central Nervous System (CNS) Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Central Nervous System (CNS) Drug market include Tekeda, Teva, Shanghai Fosun, Johnson & Johnson, Novartis AG, Roche, Eli Lilly, Jiangsu Nhwa Pharmaceutical Co., Ltd. and Pfizer Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Central Nervous System (CNS) Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Central Nervous System (CNS) Drug market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Central Nervous System (CNS) Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Central Nervous System (CNS) Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Central Nervous System (CNS) Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Central Nervous System (CNS) Drug Market by Company

Tekeda

Teva

Shanghai Fosun

Johnson & Johnson

Novartis AG

Roche

Eli Lilly

Jiangsu Nhwa Pharmaceutical Co., Ltd.

Pfizer Inc

GSK

UCB

Otsuka Pharmaceutical Co., Ltd

Boehringer Ingelheim

Biogen Inc

Central Nervous System (CNS) Drug Segment by Type

Prescription Drugs

OTC

Central Nervous System (CNS) Drug Segment by Application

Epilepsy Drugs

MS Therapeutics

Antipsychotic Drugs

Depression Drugs

Others

Central Nervous System (CNS) Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Central Nervous System (CNS) Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Central Nervous System (CNS) Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Central Nervous System (CNS) Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Central Nervous System (CNS) Drug companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Central Nervous System (CNS) Drug Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Central Nervous System (CNS) Drug Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Central Nervous System (CNS) Drug Market Share by Region (2021-2026) Table 4. Global Central Nervous System (CNS) Drug Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Central Nervous System (CNS) Drug Market Share by Region (2027-2032) Table 6. Global Central Nervous System (CNS) Drug Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Central Nervous System (CNS) Drug Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Central Nervous System (CNS) Drug Market Size Share by Type (2021-2026) Table 9. Global Central Nervous System (CNS) Drug Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Central Nervous System (CNS) Drug Market Size Share Forecasted by Type (2027-2032) Table 11. North America Central Nervous System (CNS) Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Central Nervous System (CNS) Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Central Nervous System (CNS) Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Central Nervous System (CNS) Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Central Nervous System (CNS) Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Central Nervous System (CNS) Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Central Nervous System (CNS) Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Central Nervous System (CNS) Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Central Nervous System (CNS) Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Central Nervous System (CNS) Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Central Nervous System (CNS) Drug Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Central Nervous System (CNS) Drug Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Central Nervous System (CNS) Drug Market Size Share by Application (2021-2026) Table 24. Global Central Nervous System (CNS) Drug Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Central Nervous System (CNS) Drug Market Size Share Forecasted by Application (2027-2032) Table 26. North America Central Nervous System (CNS) Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Central Nervous System (CNS) Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Central Nervous System (CNS) Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Central Nervous System (CNS) Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Central Nervous System (CNS) Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Central Nervous System (CNS) Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Central Nervous System (CNS) Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Central Nervous System (CNS) Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Central Nervous System (CNS) Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Central Nervous System (CNS) Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Central Nervous System (CNS) Drug Industry Trends Table 37. Central Nervous System (CNS) Drug Industry Drivers Table 38. Central Nervous System (CNS) Drug Industry Opportunities and Challenges Table 39. Central Nervous System (CNS) Drug Industry Restraints Table 40. Global Central Nervous System (CNS) Drug Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Central Nervous System (CNS) Drug Revenue Market Share by Company (2021-2026) Table 42. Global Central Nervous System (CNS) Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Central Nervous System (CNS) Drug Key Company Headquarters & Area Served Table 44. Global Central Nervous System (CNS) Drug Company, Product Type & Application Table 45. Global Central Nervous System (CNS) Drug Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Central Nervous System (CNS) Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Tekeda Company Information Table 49. Tekeda Business Overview Table 50. Tekeda Central Nervous System (CNS) Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Tekeda Central Nervous System (CNS) Drug Product Portfolio Table 52. Tekeda Recent Development Table 53. Teva Company Information Table 54. Teva Business Overview Table 55. Teva Central Nervous System (CNS) Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Teva Central Nervous System (CNS) Drug Product Portfolio Table 57. Teva Recent Development Table 58. Shanghai Fosun Company Information Table 59. Shanghai Fosun Business Overview Table 60. Shanghai Fosun Central Nervous System (CNS) Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Shanghai Fosun Central Nervous System (CNS) Drug Product Portfolio Table 62. Shanghai Fosun Recent Development Table 63. Johnson & Johnson Company Information Table 64. Johnson & Johnson Business Overview Table 65. Johnson & Johnson Central Nervous System (CNS) Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Johnson & Johnson Central Nervous System (CNS) Drug Product Portfolio Table 67. Johnson & Johnson Recent Development Table 68. Novartis AG Company Information Table 69. Novartis AG Business Overview Table 70. Novartis AG Central Nervous System (CNS) Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Novartis AG Central Nervous System (CNS) Drug Product Portfolio Table 72. Novartis AG Recent Development Table 73. Roche Company Information Table 74. Roche Business Overview Table 75. Roche Central Nervous System (CNS) Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Roche Central Nervous System (CNS) Drug Product Portfolio Table 77. Roche Recent Development Table 78. Eli Lilly Company Information Table 79. Eli Lilly Business Overview Table 80. Eli Lilly Central Nervous System (CNS) Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Eli Lilly Central Nervous System (CNS) Drug Product Portfolio Table 82. Eli Lilly Recent Development Table 83. Jiangsu Nhwa Pharmaceutical Co., Ltd. Company Information Table 84. Jiangsu Nhwa Pharmaceutical Co., Ltd. Business Overview Table 85. Jiangsu Nhwa Pharmaceutical Co., Ltd. Central Nervous System (CNS) Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Jiangsu Nhwa Pharmaceutical Co., Ltd. Central Nervous System (CNS) Drug Product Portfolio Table 87. Jiangsu Nhwa Pharmaceutical Co., Ltd. Recent Development Table 88. Pfizer Inc Company Information Table 89. Pfizer Inc Business Overview Table 90. Pfizer Inc Central Nervous System (CNS) Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Pfizer Inc Central Nervous System (CNS) Drug Product Portfolio Table 92. Pfizer Inc Recent Development Table 93. GSK Company Information Table 94. GSK Business Overview Table 95. GSK Central Nervous System (CNS) Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. GSK Central Nervous System (CNS) Drug Product Portfolio Table 97. GSK Recent Development Table 98. UCB Company Information Table 99. UCB Business Overview Table 100. UCB Central Nervous System (CNS) Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. UCB Central Nervous System (CNS) Drug Product Portfolio Table 102. UCB Recent Development Table 103. Otsuka Pharmaceutical Co., Ltd Company Information Table 104. Otsuka Pharmaceutical Co., Ltd Business Overview Table 105. Otsuka Pharmaceutical Co., Ltd Central Nervous System (CNS) Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Otsuka Pharmaceutical Co., Ltd Central Nervous System (CNS) Drug Product Portfolio Table 107. Otsuka Pharmaceutical Co., Ltd Recent Development Table 108. Boehringer Ingelheim Company Information Table 109. Boehringer Ingelheim Business Overview Table 110. Boehringer Ingelheim Central Nervous System (CNS) Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Boehringer Ingelheim Central Nervous System (CNS) Drug Product Portfolio Table 112. Boehringer Ingelheim Recent Development Table 113. Biogen Inc Company Information Table 114. Biogen Inc Business Overview Table 115. Biogen Inc Central Nervous System (CNS) Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Biogen Inc Central Nervous System (CNS) Drug Product Portfolio Table 117. Biogen Inc Recent Development Table 118. North America Central Nervous System (CNS) Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. North America Central Nervous System (CNS) Drug Market Size by Country (2021-2026) & (US$ Million) Table 120. North America Central Nervous System (CNS) Drug Market Share by Country (2021-2026) Table 121. North America Central Nervous System (CNS) Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. North America Central Nervous System (CNS) Drug Market Share Forecast by Country (2027-2032) Table 123. Europe Central Nervous System (CNS) Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. Europe Central Nervous System (CNS) Drug Market Size by Country (2021-2026) & (US$ Million) Table 125. Europe Central Nervous System (CNS) Drug Market Share by Country (2021-2026) Table 126. Europe Central Nervous System (CNS) Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. Europe Central Nervous System (CNS) Drug Market Share Forecast by Country (2027-2032) Table 128. Asia-Pacific Central Nervous System (CNS) Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Asia-Pacific Central Nervous System (CNS) Drug Market Size by Country (2021-2026) & (US$ Million) Table 130. Asia-Pacific Central Nervous System (CNS) Drug Market Share by Country (2021-2026) Table 131. Asia-Pacific Central Nervous System (CNS) Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Asia-Pacific Central Nervous System (CNS) Drug Market Share Forecast by Country (2027-2032) Table 133. Latin America Central Nervous System (CNS) Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Latin America Central Nervous System (CNS) Drug Market Size by Country (2021-2026) & (US$ Million) Table 135. Latin America Central Nervous System (CNS) Drug Market Share by Country (2021-2026) Table 136. Latin America Central Nervous System (CNS) Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Latin America Central Nervous System (CNS) Drug Market Share Forecast by Country (2027-2032) Table 138. Middle East & Africa Central Nervous System (CNS) Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Middle East & Africa Central Nervous System (CNS) Drug Market Size by Country (2021-2026) & (US$ Million) Table 140. Middle East & Africa Central Nervous System (CNS) Drug Market Share by Country (2021-2026) Table 141. Middle East & Africa Central Nervous System (CNS) Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Middle East & Africa Central Nervous System (CNS) Drug Market Share Forecast by Country (2027-2032) Table 143. Research Programs/Design for This Report Table 144. Authors List of This Report Table 145. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Central Nervous System (CNS) Drug Product Image Figure 3. Global Central Nervous System (CNS) Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Central Nervous System (CNS) Drug Market Size (2021-2032) & (US$ Million) Figure 5. Global Central Nervous System (CNS) Drug Market Share by Region: 2025 VS 2032 Figure 6. Global Central Nervous System (CNS) Drug Market Share by Region (2021-2032) Figure 7. North America Central Nervous System (CNS) Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Central Nervous System (CNS) Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Central Nervous System (CNS) Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Central Nervous System (CNS) Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Central Nervous System (CNS) Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Prescription Drugs Image Figure 13. Global Prescription Drugs Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. OTC Image Figure 15. Global OTC Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Global Central Nervous System (CNS) Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 17. Global Central Nervous System (CNS) Drug Market Share by Type 2025 VS 2032 Figure 18. North America Central Nervous System (CNS) Drug Market Size Share by Type (2021-2032) Figure 19. Europe Central Nervous System (CNS) Drug Market Size Share by Type (2021-2032) Figure 20. Asia-Pacific Central Nervous System (CNS) Drug Market Size Share by Type (2021-2032) Figure 21. Latin America Central Nervous System (CNS) Drug Market Size Share by Type (2021-2032) Figure 22. Middle East and Africa Central Nervous System (CNS) Drug Market Size Share by Type (2021-2032) Figure 23. Epilepsy Drugs Image Figure 24. Global Epilepsy Drugs Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. MS Therapeutics Image Figure 26. Global MS Therapeutics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Antipsychotic Drugs Image Figure 28. Global Antipsychotic Drugs Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Depression Drugs Image Figure 30. Global Depression Drugs Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Others Image Figure 32. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Global Central Nervous System (CNS) Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Central Nervous System (CNS) Drug Market Share by Application 2025 VS 2032 Figure 35. North America Central Nervous System (CNS) Drug Market Size Share by Application (2021-2032) Figure 36. Europe Central Nervous System (CNS) Drug Market Size Share by Application (2021-2032) Figure 37. Asia-Pacific Central Nervous System (CNS) Drug Market Size Share by Application (2021-2032) Figure 38. Latin America Central Nervous System (CNS) Drug Market Size Share by Application (2021-2032) Figure 39. Middle East and Africa Central Nervous System (CNS) Drug Market Size Share by Application (2021-2032) Figure 40. Global Top 5 and 10 Central Nervous System (CNS) Drug Players Market Share by Revenue in 2025 Figure 41. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 42. North America Central Nervous System (CNS) Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 43. North America Central Nervous System (CNS) Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 44. North America Central Nervous System (CNS) Drug Market Share by Country (2021-2032) Figure 45. Europe Central Nervous System (CNS) Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Central Nervous System (CNS) Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Central Nervous System (CNS) Drug Market Share by Country (2021-2032) Figure 48. Asia-Pacific Central Nervous System (CNS) Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 49. Asia-Pacific Central Nervous System (CNS) Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 50. Asia-Pacific Central Nervous System (CNS) Drug Market Share by Country (2021-2032) Figure 51. Latin America Central Nervous System (CNS) Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Latin America Central Nervous System (CNS) Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Central Nervous System (CNS) Drug Market Share by Country (2021-2032) Figure 54. Middle East & Africa Central Nervous System (CNS) Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Middle East & Africa Central Nervous System (CNS) Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 56. Middle East & Africa Central Nervous System (CNS) Drug Market Share by Country (2021-2032) Figure 57. Years Considered Figure 58. Research Process Figure 59. Key Executives Interviewed

Scope & coverage.

Types
  • Prescription Drugs
  • OTC
Applications
  • Epilepsy Drugs
  • MS Therapeutics
  • Antipsychotic Drugs
  • Depression Drugs
  • Others
Companies covered
  • Tekeda
  • Teva
  • Shanghai Fosun
  • Johnson & Johnson
  • Novartis AG
  • Roche
  • Eli Lilly
  • Jiangsu Nhwa Pharmaceutical Co., Ltd.
  • Pfizer Inc
  • GSK
  • UCB
  • Otsuka Pharmaceutical Co., Ltd
  • Boehringer Ingelheim
  • Biogen Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Central Nervous System (CNS) Drug Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Central Nervous System (CNS) Drug Market Size by Region (2021-2032)
  5. 1.4.1 Global Central Nervous System (CNS) Drug Market Size by Region (2021-2026)
  6. 1.4.2 Global Central Nervous System (CNS) Drug Market Size by Region (2027-2032)
  7. 1.5 Key Regions Central Nervous System (CNS) Drug Market Size (2021-2032)
  8. 1.5.1 North America Central Nervous System (CNS) Drug Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Central Nervous System (CNS) Drug Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Central Nervous System (CNS) Drug Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Central Nervous System (CNS) Drug Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Central Nervous System (CNS) Drug Market Size Growth Rate (2021-2032)
2 Central Nervous System (CNS) Drug Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Prescription Drugs
  3. 2.1.2 OTC
  4. 2.2 Global Central Nervous System (CNS) Drug Market Size by Type
  5. 2.2.1 Global Central Nervous System (CNS) Drug Market Size Overview by Type (2021-2032)
  6. 2.2.2 Global Central Nervous System (CNS) Drug Historic Market Size Review by Type (2021-2026)
  7. 2.2.3 Global Central Nervous System (CNS) Drug Market Size Forecasted by Type (2027-2032)
  8. 2.3 Global Central Nervous System (CNS) Drug Market Size by Regions
  9. 2.3.1 North America Central Nervous System (CNS) Drug Market Size Breakdown by Type (2021-2026)
  10. 2.3.2 Europe Central Nervous System (CNS) Drug Market Size Breakdown by Type (2021-2026)
  11. 2.3.3 Asia-Pacific Central Nervous System (CNS) Drug Market Size Breakdown by Type (2021-2026)
  12. 2.3.4 South America Central Nervous System (CNS) Drug Market Size Breakdown by Type (2021-2026)
  13. 2.3.5 Middle East and Africa Central Nervous System (CNS) Drug Market Size Breakdown by Type (2021-2026)
3 Central Nervous System (CNS) Drug Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Epilepsy Drugs
  3. 3.1.2 MS Therapeutics
  4. 3.1.3 Antipsychotic Drugs
  5. 3.1.4 Depression Drugs
  6. 3.1.5 Others
  7. 3.2 Global Central Nervous System (CNS) Drug Market Size by Application
  8. 3.2.1 Global Central Nervous System (CNS) Drug Market Size Overview by Application (2021-2032)
  9. 3.2.2 Global Central Nervous System (CNS) Drug Historic Market Size Review by Application (2021-2026)
  10. 3.2.3 Global Central Nervous System (CNS) Drug Market Size Forecasted by Application (2027-2032)
  11. 3.3 Global Central Nervous System (CNS) Drug Market Size by Regions
  12. 3.3.1 North America Central Nervous System (CNS) Drug Market Size Breakdown by Application (2021-2026)
  13. 3.3.2 Europe Central Nervous System (CNS) Drug Market Size Breakdown by Application (2021-2026)
  14. 3.3.3 Asia-Pacific Central Nervous System (CNS) Drug Market Size Breakdown by Application (2021-2026)
  15. 3.3.4 South America Central Nervous System (CNS) Drug Market Size Breakdown by Application (2021-2026)
  16. 3.3.5 Middle East and Africa Central Nervous System (CNS) Drug Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Central Nervous System (CNS) Drug Industry Trends
  2. 4.2 Central Nervous System (CNS) Drug Industry Drivers
  3. 4.3 Central Nervous System (CNS) Drug Industry Opportunities and Challenges
  4. 4.4 Central Nervous System (CNS) Drug Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Central Nervous System (CNS) Drug Revenue (2021-2026)
  2. 5.2 Global Central Nervous System (CNS) Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Central Nervous System (CNS) Drug Key Company Headquarters & Area Served
  4. 5.4 Global Central Nervous System (CNS) Drug Company, Product Type & Application
  5. 5.5 Global Central Nervous System (CNS) Drug Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Central Nervous System (CNS) Drug Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Central Nervous System (CNS) Drug Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Central Nervous System (CNS) Drug Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Tekeda
  2. 6.1.1 Tekeda Company Information
  3. 6.1.2 Tekeda Business Overview
  4. 6.1.3 Tekeda Central Nervous System (CNS) Drug Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Tekeda Central Nervous System (CNS) Drug Product Portfolio
  6. 6.1.5 Tekeda Recent Developments
  7. 6.2 Teva
  8. 6.2.1 Teva Company Information
  9. 6.2.2 Teva Business Overview
  10. 6.2.3 Teva Central Nervous System (CNS) Drug Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Teva Central Nervous System (CNS) Drug Product Portfolio
  12. 6.2.5 Teva Recent Developments
  13. 6.3 Shanghai Fosun
  14. 6.3.1 Shanghai Fosun Company Information
  15. 6.3.2 Shanghai Fosun Business Overview
  16. 6.3.3 Shanghai Fosun Central Nervous System (CNS) Drug Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Shanghai Fosun Central Nervous System (CNS) Drug Product Portfolio
  18. 6.3.5 Shanghai Fosun Recent Developments
  19. 6.4 Johnson & Johnson
  20. 6.4.1 Johnson & Johnson Company Information
  21. 6.4.2 Johnson & Johnson Business Overview
  22. 6.4.3 Johnson & Johnson Central Nervous System (CNS) Drug Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Johnson & Johnson Central Nervous System (CNS) Drug Product Portfolio
  24. 6.4.5 Johnson & Johnson Recent Developments
  25. 6.5 Novartis AG
  26. 6.5.1 Novartis AG Company Information
  27. 6.5.2 Novartis AG Business Overview
  28. 6.5.3 Novartis AG Central Nervous System (CNS) Drug Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Novartis AG Central Nervous System (CNS) Drug Product Portfolio
  30. 6.5.5 Novartis AG Recent Developments
  31. 6.6 Roche
  32. 6.6.1 Roche Company Information
  33. 6.6.2 Roche Business Overview
  34. 6.6.3 Roche Central Nervous System (CNS) Drug Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Roche Central Nervous System (CNS) Drug Product Portfolio
  36. 6.6.5 Roche Recent Developments
  37. 6.7 Eli Lilly
  38. 6.7.1 Eli Lilly Company Information
  39. 6.7.2 Eli Lilly Business Overview
  40. 6.7.3 Eli Lilly Central Nervous System (CNS) Drug Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Eli Lilly Central Nervous System (CNS) Drug Product Portfolio
  42. 6.7.5 Eli Lilly Recent Developments
  43. 6.8 Jiangsu Nhwa Pharmaceutical Co., Ltd.
  44. 6.8.1 Jiangsu Nhwa Pharmaceutical Co., Ltd. Company Information
  45. 6.8.2 Jiangsu Nhwa Pharmaceutical Co., Ltd. Business Overview
  46. 6.8.3 Jiangsu Nhwa Pharmaceutical Co., Ltd. Central Nervous System (CNS) Drug Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Jiangsu Nhwa Pharmaceutical Co., Ltd. Central Nervous System (CNS) Drug Product Portfolio
  48. 6.8.5 Jiangsu Nhwa Pharmaceutical Co., Ltd. Recent Developments
  49. 6.9 Pfizer Inc
  50. 6.9.1 Pfizer Inc Company Information
  51. 6.9.2 Pfizer Inc Business Overview
  52. 6.9.3 Pfizer Inc Central Nervous System (CNS) Drug Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Pfizer Inc Central Nervous System (CNS) Drug Product Portfolio
  54. 6.9.5 Pfizer Inc Recent Developments
  55. 6.10 GSK
  56. 6.10.1 GSK Company Information
  57. 6.10.2 GSK Business Overview
  58. 6.10.3 GSK Central Nervous System (CNS) Drug Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 GSK Central Nervous System (CNS) Drug Product Portfolio
  60. 6.10.5 GSK Recent Developments
  61. 6.11 UCB
  62. 6.11.1 UCB Company Information
  63. 6.11.2 UCB Business Overview
  64. 6.11.3 UCB Central Nervous System (CNS) Drug Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 UCB Central Nervous System (CNS) Drug Product Portfolio
  66. 6.11.5 UCB Recent Developments
  67. 6.12 Otsuka Pharmaceutical Co., Ltd
  68. 6.12.1 Otsuka Pharmaceutical Co., Ltd Company Information
  69. 6.12.2 Otsuka Pharmaceutical Co., Ltd Business Overview
  70. 6.12.3 Otsuka Pharmaceutical Co., Ltd Central Nervous System (CNS) Drug Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Otsuka Pharmaceutical Co., Ltd Central Nervous System (CNS) Drug Product Portfolio
  72. 6.12.5 Otsuka Pharmaceutical Co., Ltd Recent Developments
  73. 6.13 Boehringer Ingelheim
  74. 6.13.1 Boehringer Ingelheim Company Information
  75. 6.13.2 Boehringer Ingelheim Business Overview
  76. 6.13.3 Boehringer Ingelheim Central Nervous System (CNS) Drug Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Boehringer Ingelheim Central Nervous System (CNS) Drug Product Portfolio
  78. 6.13.5 Boehringer Ingelheim Recent Developments
  79. 6.14 Biogen Inc
  80. 6.14.1 Biogen Inc Company Information
  81. 6.14.2 Biogen Inc Business Overview
  82. 6.14.3 Biogen Inc Central Nervous System (CNS) Drug Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Biogen Inc Central Nervous System (CNS) Drug Product Portfolio
  84. 6.14.5 Biogen Inc Recent Developments
7 North America
  1. 7.1 North America Central Nervous System (CNS) Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Central Nervous System (CNS) Drug Market Size by Country (2021-2026)
  3. 7.3 North America Central Nervous System (CNS) Drug Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Central Nervous System (CNS) Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Central Nervous System (CNS) Drug Market Size by Country (2021-2026)
  3. 8.3 Europe Central Nervous System (CNS) Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Central Nervous System (CNS) Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Central Nervous System (CNS) Drug Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Central Nervous System (CNS) Drug Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Central Nervous System (CNS) Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Central Nervous System (CNS) Drug Market Size by Country (2021-2026)
  3. 10.3 South America Central Nervous System (CNS) Drug Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Central Nervous System (CNS) Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Central Nervous System (CNS) Drug Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Central Nervous System (CNS) Drug Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst